return2ozma@lemmy.world to News@lemmy.world · 1 year agoOzempic maker Novo Nordisk facing pressure as study finds $1,000 appetite suppressant can be made for just $5fortune.comexternal-linkmessage-square101fedilinkarrow-up1497arrow-down111
arrow-up1486arrow-down1external-linkOzempic maker Novo Nordisk facing pressure as study finds $1,000 appetite suppressant can be made for just $5fortune.comreturn2ozma@lemmy.world to News@lemmy.world · 1 year agomessage-square101fedilink
minus-squareEnderMB@lemmy.worldlinkfedilinkarrow-up6·1 year agoI’m sure there are some costs associated with developing drugs, and I’m sure it’s not cheap. The problem still stands, though, and the solution is capping executive pay in public companies.
I’m sure there are some costs associated with developing drugs, and I’m sure it’s not cheap.
The problem still stands, though, and the solution is capping executive pay in public companies.